diversification.com

SRPT

Companies
NASDAQ
Sarepta Therapeutics Inc.
Health Care
OverviewNewsRisk & CorrelationForecasts
Price Chart
Overview

About SRPT

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Market Cap
$11.7B
Volume
169.6M
Avg. Volume
89.5M
P/E Ratio
3.1816595
Dividend Yield
0.00%
Employees
1.3K

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for SRPT

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

June 16, 2025

Sarepta's gene therapy medicine kills patient, CEO suspends full year guidance

June 16, 2025

SRPT Stock: What's Happening With Sarepta Therapeutics?

June 17, 2025

SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion

June 16, 2025
Risk & Correlation Analysis
Market Correlation
0.70
Low Correlation
Volatility
High (0.47)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SRPT.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SRPT shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$11.7B
Volume169.6M
P/E Ratio3.18
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025
Related Securities
ARKG
ARK Genomic Revolution ETF
VRTX
Vertex Pharmaceuticals Inc.
MRNA
Moderna Inc.
REGN
Regeneron Pharmaceuticals, Inc.
IONS
Ionis Pharmaceuticals Inc.
ILMN
Illumina, Inc.

PortfolioPilot Analysis

Get AI-powered insights on how SRPT fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025